Mutual of America Capital Management LLC Sells 915 Shares of Masimo Co. (NASDAQ:MASI)

Mutual of America Capital Management LLC lessened its stake in Masimo Co. (NASDAQ:MASI) by 3.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,532 shares of the medical equipment provider’s stock after selling 915 shares during the period. Mutual of America Capital Management LLC’s holdings in Masimo were worth $3,216,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in MASI. Riverview Trust Co purchased a new position in shares of Masimo during the first quarter worth approximately $25,000. GAMMA Investing LLC boosted its position in Masimo by 75.0% during the 2nd quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider’s stock valued at $33,000 after buying an additional 111 shares during the period. EverSource Wealth Advisors LLC grew its holdings in Masimo by 851.6% in the 4th quarter. EverSource Wealth Advisors LLC now owns 295 shares of the medical equipment provider’s stock worth $35,000 after acquiring an additional 264 shares during the last quarter. Parallel Advisors LLC increased its position in shares of Masimo by 48.3% in the fourth quarter. Parallel Advisors LLC now owns 445 shares of the medical equipment provider’s stock valued at $52,000 after acquiring an additional 145 shares during the period. Finally, HHM Wealth Advisors LLC boosted its holdings in shares of Masimo by 25.0% during the second quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider’s stock worth $79,000 after purchasing an additional 125 shares during the period. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Trading Up 2.9 %

MASI opened at $125.00 on Tuesday. The stock has a market cap of $6.65 billion, a PE ratio of 85.03 and a beta of 0.98. The business has a 50 day moving average of $115.33 and a 200-day moving average of $124.91. Masimo Co. has a 52 week low of $75.22 and a 52 week high of $153.93. The company has a quick ratio of 1.15, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.77 by $0.09. The company had revenue of $496.30 million during the quarter, compared to analysts’ expectations of $493.92 million. Masimo had a net margin of 3.94% and a return on equity of 14.07%. Masimo’s revenue was up 9.0% on a year-over-year basis. During the same period last year, the company posted $0.62 EPS. Equities research analysts predict that Masimo Co. will post 3.87 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Friday. Piper Sandler boosted their target price on Masimo from $160.00 to $165.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Four analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $144.67.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.